Variant report

Variant	rs12201737
Chromosome Location	chr6:25407482-25407483
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 13 )
Associated
traits (count: 4 )

rSNPs within LD-proxies of this variant (count:8)

rs_ID	r²[population]
rs10946770	0.94[CEU][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6906654	0.85[CHD][hapmap]
rs716796	0.88[CEU][hapmap];0.81[EUR][1000 genomes]
rs716798	0.82[CEU][hapmap];0.81[EUR][1000 genomes]
rs880225	0.94[CEU][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.94[MEX][hapmap];1.00[TSI][hapmap];0.92[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs9461152	0.81[EUR][1000 genomes]
rs9461153	0.83[EUR][1000 genomes]
rs9467501	1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv883485	chr6:25259137-25437986	Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
2	nsv883486	chr6:25260434-25422369	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
3	nsv883487	chr6:25280119-25508868	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
4	nsv830612	chr6:25342408-25509758	Enhancers Strong transcription Weak transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
5	esv1850810	chr6:25405576-25462543	Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases

mRNA abundance (count:4)

SNP	Gene	Cis/trans	Tissue	Source
rs12201737	LRRC16	Cis_1M	lymphoblastoid	RTeQTL
rs12201737	ZSCAN12	cis	cerebellum	SCAN
rs12201737	LRRC16	cis	multi-tissue	Pritchard
rs12201737	OR2B6	cis	cerebellum	SCAN

Chromatin state (count:67 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:25377400-25410600	Weak transcription	Gastric	stomach
2	chr6:25402200-25409600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr6:25403600-25408200	Enhancers	HUES48 Cell Line	embryonic stem cell
4	chr6:25403800-25410600	Weak transcription	Pancreas	Pancrea
5	chr6:25404400-25407600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr6:25404400-25410800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr6:25405200-25407600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr6:25405200-25408000	Weak transcription	Fetal Muscle Leg	muscle
9	chr6:25405200-25413200	Weak transcription	Fetal Lung	lung
10	chr6:25405400-25407600	Weak transcription	Brain Hippocampus Middle	brain
11	chr6:25405800-25407800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
12	chr6:25405800-25408600	Enhancers	Primary T cells fromperipheralblood	blood
13	chr6:25405800-25409000	Enhancers	Primary B cells from peripheral blood	blood
14	chr6:25405800-25410400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr6:25405800-25410600	Enhancers	Primary T helper cells fromperipheralblood	blood
16	chr6:25405800-25411600	Enhancers	Fetal Thymus	thymus
17	chr6:25405800-25412600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
18	chr6:25406000-25408200	Enhancers	Primary T cells from cord blood	blood
19	chr6:25406000-25408600	Enhancers	Thymus	Thymus
20	chr6:25406000-25409400	Weak transcription	Stomach Mucosa	stomach
21	chr6:25406000-25410600	Weak transcription	Fetal Intestine Small	intestine
22	chr6:25406000-25413200	Weak transcription	Skeletal Muscle Male	skeletal muscle
23	chr6:25406200-25408600	Enhancers	Primary B cells from cord blood	blood
24	chr6:25406200-25409800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr6:25406200-25410000	Enhancers	H1 Cell Line	embryonic stem cell
26	chr6:25406200-25410400	Enhancers	Primary T helper cells PMA-I stimulated	--
27	chr6:25406200-25410600	Enhancers	Primary T killer memory cells from peripheral blood	blood
28	chr6:25406200-25410600	Weak transcription	Fetal Intestine Large	intestine
29	chr6:25406200-25411600	Weak transcription	Rectal Mucosa Donor 29	rectum
30	chr6:25406400-25407600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
31	chr6:25406400-25408200	Enhancers	Right Atrium	heart
32	chr6:25406400-25410400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr6:25406400-25410400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
34	chr6:25406400-25420200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr6:25406600-25407600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
36	chr6:25406600-25408800	Enhancers	iPS-18 Cell Line	embryonic stem cell
37	chr6:25406600-25409800	Weak transcription	Small Intestine	intestine
38	chr6:25406600-25410400	Weak transcription	Rectal Mucosa Donor 31	rectum
39	chr6:25406600-25410600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
40	chr6:25406600-25410600	Weak transcription	Adipose Nuclei	Adipose
41	chr6:25406600-25410600	Weak transcription	NHEK	skin
42	chr6:25406600-25410800	Weak transcription	Lung	lung
43	chr6:25406600-25411600	Weak transcription	Colonic Mucosa	Colon
44	chr6:25406800-25410400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
45	chr6:25406800-25410600	Weak transcription	Sigmoid Colon	Sigmoid Colon
46	chr6:25407000-25407800	Enhancers	iPS-20b Cell Line	embryonic stem cell
47	chr6:25407000-25408000	Enhancers	H9 Cell Line	embryonic stem cell
48	chr6:25407000-25408200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
49	chr6:25407000-25410200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
50	chr6:25407000-25410400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links